PTAB Declares that State-Owned Patents are Immune from IPR Challenges
A panel of the Patent Trial and Appeal Board (PTAB) recently issued a decision that could significantly strengthen patent portfolios…
Buchanan Draws from Its In-Depth Post-Grant Experience to Defeat Patentability Challenges Filed Against Medical Components, Inc.
Faced with numerous challenges against two of their medical device patents, firm client Medical Components, Inc. relied on Buchanan’s specialty…
PTAB Final Written Decision Not Binding in Federal Circuit Review of Preliminary Injunction Award
The interplay between infringement actions brought in district court and parallel USPTO post-grant proceedings can lead to interesting outcomes. One…
PTAB Denies Institution of 6 Out of 6 IPR Petitions
GlaxoSmithKline LLC (GSK) filed six inter partes review (IPR) petitions to challenge the patentability of U.S. Patent Nos. 8,466,172; 8,609,646;…
Federal Circuit to Reconsider Appealability of Time-Bar Determinations in Institution Decisions
On January 4, 2017, the Federal Circuit agreed to reconsider en banc a panel decision in Wi-Fi One, LLC v.…